Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Risk adjusted net present value: What is the current valuation of JCR Pharmaceuticals's Laronidase?
Laronidase is a fusion protein commercialized by JCR Pharmaceuticals, with a leading Phase II program in Mucopolysaccharidosis I (MPS I)...
Data Insights
Risk adjusted net present value: What is the current valuation of JCR Pharmaceuticals's Laronidase?
Laronidase is a fusion protein commercialized by JCR Pharmaceuticals, with a leading Phase II program in Mucopolysaccharidosis I (MPS I)...